A Double Blind Study in Pediatric Subjects With Chronic Plaque Psoriasis, Studying Adalimumab vs. Methotrexate

NCT01251614 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

114

Enrollment

INDUSTRY

Sponsor class

Conditions

Plaque Psoriasis

Interventions

BIOLOGICAL: Adalimumab
DRUG: Methotrexate
BIOLOGICAL: Placebo to Adalimumab
DRUG: Placebo to Methotrexate

Sponsor

AbbVie (prior sponsor, Abbott)